Altimmune to participate in the leerink global healthcare conference

Gaithersburg, md., march 03, 2025 (globe newswire) -- altimmune, inc. (nasdaq: alt), a late clinical-stage biopharmaceutical company, today announced that members of the company's management team will participate in a fireside chat at the leerink global healthcare conference. details are as follows:

ALT Ratings Summary

ALT Quant Ranking